Table 3.
Characteristics of Type 2 MI Based on the Occurrence of 90-Day Cardiac Survival
| Variables | No Cardiac Death | Cardiac Death | P-value |
|---|---|---|---|
| n = 3833 | n = 493 | ||
| Age (year) | 87.86±5.18 | 91.05±5.38 | <0.0001 |
| Male, n (%) | 2737 (71.4) | 347 (70.3) | 0.6372 |
| BMI ≥ 27 kg/m², n (%) | 775 (20.2) | 91 (18.5) | 0.3577 |
| Cys C ≥ 1.49mg/L, n (%) | 2026 (52.9) | 359 (72.8) | <0.0001 |
| cTnI ≥ 1.40 ng/mL, n (%) | 1194 (31.2) | 369 (74.8%) | <0.0001 |
| ACCI | 7.93±1.89 | 9.14±2.33 | <0.0001 |
| Comorbidities, n (%) | |||
| Hypertension | 3158 (82.4) | 411 (83.4) | 0.5908 |
| Previous MI | 684 (17.8) | 113 (22.9) | 0.0048 |
| Congestive heart failure NYHA III/IV | 1101 (28.7) | 295 (59.8) | <0.0001 |
| DM | 1578 (41.2) | 206 (41.8) | 0.7936 |
| Atrial fibrillation | 1978 (51.6) | 269 (54.6) | 0.2157 |
| Dyslipidemia | 2264 (59.1) | 305 (61.8) | 0.2334 |
| Hemoglobin < 80 g/L | 708 (18.5) | 103 (20.9) | 0.1948 |
| Peripheral vascular disease | 1637 (42.7) | 216 (43.8) | 0.6406 |
| Echocardiographic results | |||
| LVEF | 51.29±11.22 | 51.78±12.01 | 0.3685 |
Note: Data are mean ± standard deviation or n (%).
Abbreviations: BMI, body mass index; Cys C, Cystatin C; cTnI, cardiac troponin I; ACCI, age-adjusted Charlson comorbidity index; MI, myocardial infarction; DM, diabetes mellitus; LVEF, left ventricular ejection fraction.